Clinical Trial

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Study acronym: BIOMAG-LL
Recruiting
View on ClinicalTrials.gov →
Summary
The study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-22; most recent amendment 2026-07-07.
Trial Details
NCT Number NCT07091682
Lead Sponsor Biotronik AG
Conditions Coronary Artery Disease, Atherosclerosis of Coronary Artery, Myocardial Ischemia, Ischemic Heart Disease, Acute Coronary Syndromes, Angina Pectoris
Enrollment 100 participants
Start Date 2025-02-18
Primary Completion 2027-06 (estimated)
Study Completion 2031-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-08